Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CDMO
Biotech
CDMO Catalent strengthens ADC pipeline with $10M Lisata pact
Catalent has continued its foray into the ADC space, this time penning a $10 million biobucks pact to evaluate Lisata’s tumor drug.
James Waldron
Oct 9, 2025 7:45am
Chinese CRO ChemPartner gets ready to debut US research facility
Aug 26, 2025 2:57pm
WuXi AppTec posts sales decline but picks up new business in Q3
Oct 29, 2024 8:25am
Biopharma Q2 VC hit highest level since ’22, while M&A slowed
Aug 23, 2024 4:00am
Charles River Labs partners with Wheeler Bio for CMC platform
Feb 26, 2024 3:15pm
QHP buys cell and gene therapy specialist Applied StemCell
Oct 9, 2023 10:20am
